Docencia, formación, investigación y 12. calidad - Hospital General ...

ATENCIÓN ESPECIALIZADA. DOCENCIA SERVICIOS
318
• Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.
• Ann Oncol 2005;16:597-601. (IF 2003: 3.605)
2. Carrato Mena A, Gallego Plazas J, Guillén Ponce C, Molina Garrido MJ.
• Tratamiento adyuvante del cáncer de colon: quimioterapia oral.
• Rev Cancer 2005;19(suppl1):112-114.
3. Merck B, Cansado P, Fernandez-Frias A, Rodriguez-Lescure A, Costa D, Lacueva FJ, Candela F, Calpena R.
• Application of the EUSOMA criteria in breast units in countries of the European Union.
• Cir Esp. 2005 Feb;77(2):65-9.
4. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Weaver C, Tomiak E, Al-Tweigeri T, Chap L, Juhos E, Guevin R, Howell A,
Fornander T, Hainsworth J, Coleman R, Vinholes J, Modiano M, Pinter T, Tang SC, Colwell B, Prady C, Provencher L, Walde D, Rodriguez-Lescure
A, Hugh J, Loret C, Rupin M, Blitz S, Jacobs P, Murawsky M, Riva A, Vogel C; Breast Cancer International Research Group
001 Investigators.
• Adjuvant docetaxel for node-positive breast cancer.
• N Engl J Med. 2005 Jun 2;352(22):2302-13.
5. Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A, Ruiz L, Jariod M, Costafreda S, Coll S, Alguacil J, Corominas JM, Solà
R, Salas R, Real FX.
• Exocrine pancreatic cancer: Symptoms at presentation and their relation with tumour site and stage.
• Clin Transl Oncol 2005;7:189-97.
6. Fortuny J, Silverman D, Malats N, Tardón A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Dosemeci M, Kogevinas M.
• Use of analgesics and aspirin in a spanish multicentric study.
• Gac Sanit 2005:19:316-20.
7. Soto JL, Barberá V, Carrato A.
• Biología Molecular del cáncer de páncreas exocrino.
• Rev Cancer 2005;19:12-26.
8. Sastre J, Marcuello E, Massuti B, Navarro M, Gil S, Antón A, Abad A, Aranda E, Maurel J, Valladares M, Maestu I, Carrato A, Vicent JM,
Díaz-Rubio E.
• Irinotecan in combination with fluorouracil in a 48 hour continuous infusion as first-line chemotherapy for elderly patients with metastatic
colorectal cancer. A Spanish Cooperative Group for the Treatment of Digestive Tumors Study.
• J Clin Oncol 2005;23:3545-51. (IF 2003: 10.864)
9. Abad A, Carrato A, Navarro M, Sastre J, Cervantes A, Antón A, Martinez-Villacampa M, Marcuello E, Massutí B, Aranda E, Manzano JL,
Guallar JL, Diaz-Rubio E.
• Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hr continuous infusion of non-modulated high-dose 5-fluorouracil as firstline
treatment for advanced colorectal cancer.
• Clin Colorectal Cancer 2005;4:384-9.
10. Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell
D, Koralewski P, Kroning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schuller J, Seitz JF, Stabuc B, Tujakowski J, Van
Hazel G, Zaluski J, Scheithauer W.
• Capecitabine as adjuvant treatment for stage III colon cancer.
• N Engl J Med 2005;352:2696-704. (IF 2003: 34.833)
11. Hernández S, López-Knowles E, Lloreta J, Kogevinas M, Jaramillo R, Amorós A, Tardón A, García-Closas R, Serra C, Carrato A, Malats N,
Real FX.
• FGFR3 and TP53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.
• Clin Cancer Res 2005;11:5444-50.(IF2003: 6.511)
12. Lacueva J, Pérez-Ramos M, Soto JL, Oliver I, Andrada E, Medrano J, Pérez-Vázquez MT, Arroyo A, Carrato A, Ferragut JA, Calpena R.
• Multidrug resistance associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohystochemistry and realtime
quantitative RT-PCR.
•
Hystopathology 2005;46:389-95. (IF 2003:2.952)
Hospital General de Elche